Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Nanjing Advanced Biomaterials and Process Equipment Research Institute Co., Ltd., established on 2018-03-29, Business scope includes research and development of materials and chemical products,Production,Sales and technical consultation and service;Research and development of special equipment for materials and chemical products,production and sales;Material and chemical product analysis,test;Materials and Chemical Engineering Design,market survey,technical consulting;Conference and Exhibition,Intellectual Property Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kumamoto Health Science University (熊本保健科学大学 Kumamoto hoken kagaku daigaku) is a private university in Kumamoto, Kumamoto, Japan, established in 2003.

Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX.

GLG Pharma, LLC has obtained worldwide licenses to develop and market pharmaceuticals derived from STAT3 inhibitor technology. STAT3 inhibitors are considered one of the most promising new approaches to treating many cancers and other hyperproliferative diseases. GLC Pharma has started clinical trials for chronic lymphocytic leukemia. Clinical trials for triple negative breast cancer and ovarian cancer. Initial clinical trials have in CLL have indicated that GLG Pharma STAT3 inhibitors are very well tolerated and safe. GLG Pharma has also developed a new technology called Gx-C3 which fools cancer cells into behaving in the laboratory as if they were still in the body. This novel laboratory testing coupled with the STAT3 inhibitors will lead to Patient Centered Personalized treatment protocols. GLG's STAT3 inhibitors reverse resistance in cancer cells of 24 approved oncology drugs and immunotherapy drugs. The lead compound, GLG-302 is being funded by the National Cancer Institute's Prevent Cancer Program to replace Tamoxifen and Raloxifene, currently prescribed to breast cancer patients that initially survive chemotherapy, radiation and surgery for Triple Negative Breast Cancer and HER2 breast cancers. GLG's compound is also in a new patent applied for intravenous formulation as well. The compounds are safe and far less toxic than the alternatives. GLG has a line of repurposed drugs that can be quickly moved to a 505(B)(2) application and one of these drugs is entering Phase 1-2 clinical trials in Poland for TNBC and other metastatic tumors as well. There are 11 repurposed compounds. GLG has 52 New Chemical Entities as well.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Inist ST Co., Ltd. engages in developing medical supply ingredients and ingredient synthesizing technology. It specializes in Active Pharmaceutical Ingredients (API) products. The company was founded in 1994 and is headquartered in Eumseong-gun, South Korea.

The Research Institute at Nationwide Children's Hospital is one of America's ten largest free-standing pediatric research centers and works to enhance the health of children by engaging in research.

Pharmadesign, Inc. provides solutions for dispensing medication. The firm's services includes patient education, training models, injection training, packing and starter kits. The company was founded by Fred Pether in 1984 and is headquartered in Warren, NJ.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd., established on 2017-05-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Intellectual Property Services(Except for patent agency services);Technology intermediary service;Science popularization service;3Dprint service;business management;Corporate Headquarters Management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Drug Clinical Trial Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Beijing Yunhui Pharmaceutical Technology Co., Ltd., established on 2016-09-20, Business scope includes biological,medicine,Health products,chemical industry,Technology development of medical devices,technology transfer,technical consulting,Technical Services;Technology Import and Export,Import and export,Agent import and export;Sales of biological reagents(Does not contain drugs);Medical Science Research and Experimental Development;data processing(limited toPUEvalue in1.5The following cloud computing data);translation service;Conference Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

China State Institute of Pharmaceutical Industry is a company headquartered in Shanghai, China and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Shanghai Mankerui Biomedical Technology Co., Ltd., established on 2011-12-20, The scope of business includes engaging in medical technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,Business Management Consulting,computer software development,data processing services,Electrical Equipment,Instrumentation,plastic products,laboratory reagent(In addition to dangerous goods)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

From Bio Co., Ltd. engages in the manufacture and sale of health functional food. It offers products for dietary, joint, gastric, immunity, intestinal and other purposes. The company was founded on June 26, 2006 and is headquartered in Suwon-si, South Korea.